Molecular modeling study of cyclic pentapeptide CXCR4 antagonists: new insight into CXCR4-FC131 interactions

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• CXCR4, a G-protein coupled receptor, is implicated in diseases like breast cancer metastasis, HIV, leukemia, and rheumatoid arthritis.
• CXCR4 is a significant drug target due to its role in various pathological conditions.
• FC131, a cyclic pentapeptide, has been identified as a potent antagonist for CXCR4.

Purpose of the Study:

• To construct a three-dimensional model of the CXCR4-FC131 complex.
• To investigate the backbone flexibility of the FC131 antagonist.
• To understand the binding interactions between FC131 and CXCR4.

Main Methods:

• Molecular dynamics simulations were performed on FC131 using its NMR structure.
• Snapshot structures from simulations were used to model the docking pose of FC131 into CXCR4.
• The resulting CXCR4-FC131 complex model was compared with existing X-ray crystal structures.

Main Results:

• A three-dimensional model of the CXCR4-FC131 complex was successfully constructed.
• The model suggests potential water-mediated interactions in the binding site.
• The modeled docking pose of FC131 into CXCR4 is consistent with experimental data.
• The final model shows some differences compared to the CXCR4-CVX15 crystal structure.

Conclusions:

• The developed model provides a structural basis for understanding CXCR4 antagonism by FC131.
• The findings support the potential of FC131 as a lead compound for CXCR4-targeting drugs.
• This model can guide the design and development of novel small-molecule CXCR4 antagonists.